Mr. Elliott changed more than 75 percent of the management positions, reduced the company’s workforce by 2,200 employees and paid down more than $2.5 billion in debt. He also stuck a $296 million deal with the U.S. Department of Justice to reduce the company’s exposure to Guidant Corporation’s legal problems. He also developed a clear strategy for the company’s entry into emerging markets.
Related Articles about the Medical Devices Market:
Hospitals, Health Groups Leverage Purchasing Power for Greener Medical Supplies
Prescription Sales Through Primary Healthcare Distributors Reached $268 Billion
Funding Cutbacks, Complex Device Approval Process Threaten Med Tech Industry
